Skip to content

Clinical trials

Phase 3 Dementia trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Dementia Phase: Phase 3 Country / region: Germany Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20031
20051
20061
20091
20121
20134
20141
20153
20162
20172
20181
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Terminated9
Recruiting3
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
TauRx Therapeutics Ltd3
AstraZeneca2
Bristol-Myers Squibb2
FORUM Pharmaceuticals Inc2
Novartis Pharmaceuticals2
Otsuka Pharmaceutical Development & Commercialization, Inc.2
ACADIA Pharmaceuticals Inc.1
Aarhus University Hospital1
Axovant Sciences Ltd.1
Bellus Health Inc. - a GSK company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Dementia22
Alzheimer Disease19
Neurodegenerative Diseases7
Brain Diseases6
Cognitive Dysfunction5
Mental Disorders4
Nervous System Diseases4
Central Nervous System Diseases3
Tauopathies3
Dementia, Vascular2

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.